Gaston-Dreyfus Remi 4
4 · Bionik Laboratories Corp. · Filed Jun 28, 2018
Insider Transaction Report
Form 4
Gaston-Dreyfus Remi
Director
Transactions
- Conversion
Common Stock
2018-06-13$0.06/sh+15,740,728$983,796→ 91,204,117 total(indirect: Shares held through RGD Investissements and Lombard International Assurance SA)
Footnotes (1)
- [F1]As previously disclosed by the reporting person on a Form 4, filed with the Securities and Exchange Commission on April 3, 2018, as of March 31, 2018, the Issuer became obligated to issue 15,740,728 shares of common stock (the "Shares") to RGD Investissements, an affiliate of the reporting person, as a result of the conversion of certain outstanding convertible promissory notes in accordance with their terms. The reporting person is filing this Form 4 to disclose that the Issuer issued the Shares as of June 13, 2018.